abstract: Mature mammalian oocytes undergo a prolonged series of cytoplasmic calcium (Ca 2+ ) oscillations at fertilization that are the cause of oocyte activation. The Ca 2+ oscillations in mammalian oocytes are driven via inositol 1,4,5-trisphosphate (IP 3 ) generation. Microinjection of the sperm-derived phospholipase C-zeta (PLCz), which generates IP 3 , causes the same pattern of Ca 2+ oscillations as observed at mammalian fertilization and it is thought to be the physiological agent that triggers oocyte activation. However, another sperm-specific protein, 'post-acrosomal WW-domain binding protein' (PAWP), has also been reported to elicit activation when injected into mammalian oocytes, and to produce a Ca 2+ increase in frog oocytes. Here we have investigated whether PAWP can induce fertilization-like Ca 2+ oscillations in mouse oocytes.
Introduction
The activation of mature MII arrested oocytes involves a series of early events that initiate embryo development, following fusion of the sperm and oocyte plasma membranes. Key events of oocyte activation include second polar body emission, cortical granule exocytosis and pronuclear formation (Stricker, 1999; Carroll, 2001; Ducibella and Fissore, 2007) . All the events of oocyte activation and subsequently early embryonic development during mammalian fertilization are triggered by a characteristic series of large cytoplasmic Ca 2+ transients known as Ca 2+ oscillations (Stricker, 1999; Ducibella and Fissore, 2007) . This spermmediated Ca 2+ release is caused via the generation of increased inositol 1,4,5-trisphosphate (IP 3 ) (Miyazaki et al., 1993; Lee et al., 2006) . It is now widely accepted that mammalian sperm delivers some specific protein factor(s) into the oocyte cytoplasm after gamete fusion and that such factor(s) triggers the prolonged Ca 2+ oscillations (Carroll, 2001; Lee et al., 2006; Kashir et al., 2010; Nomikos et al., 2013a) . Intracytoplasmic sperm injection (ICSI) has also been shown to trigger Ca 2+ oscillations in mouse and human oocytes and this observation too is consistent with the idea that the sperm contains an intracellular activating factor (Tesarik and Sousa, 1994; Nakano et al., 1997) . The nature and identity of the 'sperm factor' and how it causes increased IP 3 production have been the key issues to be resolved in this field (Dale et al., 2010; Nomikos et al., 2013a) . Over the last decade, several lines of evidence suggest that the physiological sperm factor responsible for generating Ca 2+ oscillations and subsequent oocyte activation is a testis-specific isoform of phospholipase C, named PLC-zeta, PLCz Cox et al., 2002; These authors contributed equally to this work.
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For Permissions, please email: journals.permissions@oup.com Yoon et al., 2008; Kashir et al., 2010; Nomikos et al., 2013a; 2013b) . Microinjection of PLCz cRNA or recombinant PLCz protein into mouse oocytes triggered Ca 2+ oscillations similar to those seen at fertilization Kouchi et al., 2004; Yoda et al., 2004) . Injection of cognate PLCz cRNA into human, bovine and pig oocytes also triggered a prolonged series of Ca 2+ oscillations (Rogers et al., 2004; Yoneda et al., 2006; Cooney et al., 2010) , leading to meiotic resumption, pronuclear formation and development up to the blastocyst stage Yoda et al., 2004; Lee et al., 2006; Nomikos et al., 2013a) . By measuring the expression of luciferase-tagged PLCz following microinjection of its mRNA into mouse oocytes, it has been estimated that the amount of PLCz protein required to initiate Ca 2+ oscillations is 30 fg in mouse oocytes, which is within the estimates (20 -50 fg) for the amount of PLCz in a single mouse sperm (Nomikos et al., 2005; 2011a) . PLCz has been reported to be 130 fg/sperm in bulls (Cooney et al., 2010) . PLCz has also been capable of explaining Ca 2+ oscillations and oocyte activation after ICSI in the mouse. Extracts of the perinuclear matrix of mouse sperm were shown to contain an oocyte-activating factor and this factor was identified as PLCz (Fujimoto et al., 2004) . Further evidence that PLCz is important in fertilization comes from findings that its levels in human sperm are either severely low, or completely absent in sperm samples associated with failed fertilization after ICSI (Heytens et al., 2009; Kashir et al., 2010) . These data strongly suggest that PLCz is the agent used by sperm to induce Ca 2+ oscillations and oocyte activation at fertilization Nomikos et al., 2013a) . PLCz is not the only protein factor that has been proposed to underlie oocyte activation at fertilization. Post-acrosomal WW-domain binding protein (PAWP) is a sperm-specific protein found in the postacrosomal region of the perinuclear matrix, that underlies the plasma membrane in the sperm head (Wu et al., 2007) . The post-acrosomal region of the perinuclear matrix is at the posterior end of the sperm head, and considered to be the first region of the sperm that is exposed to the oocyte cytoplasm after gamete fusion. PAWP can also be extracted from the perinuclear matrix of mammalian sperm, and microinjection of recombinant PAWP protein into porcine, bovine, and monkey oocytes has been reported to trigger oocyte activation as judged by pronuclear formation (Wu et al., 2007) . In bull sperm, PAWP is present at 80 fg/sperm, which in molar equivalents is similar to reported levels of PLCz in bull sperm (Cooney et al., 2010) . PAWP shows sequence homology to the N-terminal half of WW-domain-binding protein 2, while its C terminal half is rich in proline residues (Wu et al., 2007) . In addition, the C-terminal region contains a functional PPXY consensus binding site for Group-I WW domain-containing proteins, alongside numerous unique repeating motifs (YGXPPXG) (Wu et al., 2007) . The ability of PAWP to activate oocytes was blocked upon co-injection with competitive peptides corresponding to the PPXY motif derived from PAWP (Wu et al., 2007) . Furthermore, in porcine oocytes injected with antibodies or competitive inhibitors against PAWP, sperm-induced pronuclear formation was not observed after ICSI (Wu et al., 2007) . More significantly, it has been proposed that PAWP may be the physiological agent that activates oocyte via causing Ca 2+ release, because PAWP injection was reported to activate Xenopus eggs through an associated rise in intracellular Ca 2+ (Aarabi et al., 2010 
Materials and Methods

Cloning of PAWP expression constructs
Mouse PAWP (GenBank TM accession number BC119520) was amplified by polymerase chain reaction (PCR) from a pCR-BluntII-TOPO-PAWP plasmid (GE Healthcare) using Phusion polymerase (Finnzymes, Fisher Scientific, Loughborough, UK) and the appropriate primers to incorporate a 5 ′ -SalI site and a 3 ′ -NotI site and was cloned into pETMM60 to enable bacterial protein expression. The primers used were: 5 ′ -CACCGTCGACATGG CAGTGAACCAGAACC-3 ′ (forward) and 5 ′ -GGAAGCGGCCGCTCAC ATCTTAGAGCGGGGAGAGTGG-3 ′ (reverse). For pCR3-PAWP plasmid, mouse PAWP was amplified by PCR from the pCR-BluntII-TOPO-PAWP plasmid in the same manner using Phusion polymerase (Finnzymes) and the appropriate primers to incorporate a 5 ′ -EcoRV site and a 3 ′ -NotI site, and was cloned into a pCR3 vector, or a modified pCR3 vector containing an N ′ -terminal eYFP tag. The primers used were: 5 ′ -AGCTGATATCATGG CAGTGAACCAGAACC-3 ′ (forward) and 5 ′ -GGAAGCGGCCGCTCACA TCTTAGAGCGGGGAGAGTGG-3 ′ (reverse). For pCR3-PAWP-luciferase, a three-step cloning strategy was used. Mouse PAWP was amplified by PCR from pCR-BluntII-TOPO-PAWP in the same manner using Phusion polymerase (Finnzymes) and the appropriate primers to incorporate a 5 ′ -EcoRV site and a 3 ′ -NotI site in which the stop codon had been removed and cloned into the pCR3 vector. The primers used were: 5 ′ -AGCTGATATCATGGCAGTGAACCAGAACC-3 ′ (forward) and 5 ′ -GGAAGCGGCCGCGCACATCTTAGAGCGGGGAGA GTGG-3 ′ (reverse). Finally, the firefly (Photinus pyralis) luciferase open reading frame was amplified from the pGL2 plasmid (Promega) with primers incorporating NotI sites and the product was cloned into the NotI site of the pCR3-PAWP plasmid. The primers used were: 5 ′ -CACTGCGGCC GCGATGGAAGACGCCAAAAACATAAAGA-3 ′ (forward) and 5 ′ -GCAG GCGGCCGCTTACAATTTGGACTTTCCGCCCTTC-3 ′ (reverse). Successful cloning of the above expression vector constructs was confirmed by dideoxynucleotide-sequencing (Applied Biosystems Big-Dye Ver 3.1 chemistry and model 3730 automated capillary DNA sequencer by DNA Sequencing & Services TM ).
Protein expression and purification
For NusA-6xHis-fusion protein expression, Escherichia coli [BL21-CodonPlus(DE3)-RILP; Stratagene] was transformed with the appropriate pETMM60 plasmid, cultured at 378C until A 600 reached 0.6 and protein expression induced for 18 h, at 168C with 0.1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) (ForMedium). Cells were harvested (6000g for 10 min), resuspended in phosphate-buffered saline (PBS) containing a protease inhibitor mixture (EDTA-free; Roche) and sonicated 4 × 15 s on ice. Soluble NusA-6xHis-tagged fusion protein was purified on nickel nitrilotriacetic acid resin following standard procedures (Qiagen), and eluted with 250 mM imidazole. Eluted proteins were dialysed overnight [10 000 molecular weight cut-off (MWCO); Pierce] at 48C against 4 l of PBS, and concentrated with centrifugal concentrators (Sartorius; 10 000 MWCO).
SDS -PAGE and western blotting
Recombinant proteins were separated by SDS -PAGE as described previously (Nomikos et al., 2005; 2011a, b) . Separated proteins were transferred onto polyvinylidene difluoride membranes (Immobilon-P; Millipore) using a semidry transfer system (Trans-Blot SD; Bio-Rad) in transfer buffer (48 mM Tris, 39 mM glycine, 0.0375% SDS, 20% v/v methanol) at 20 V for 1 h. Membranes were incubated overnight at 48C in Tris-buffered saline, 0.1% Tween 20 containing 5% non-fat milk powder, and probed with a PentaHis monoclonal antibody (Qiagen) (1 : 5000 dilution). Detection of horseradish peroxidase-coupled secondary antibody was achieved using enhanced chemiluminescence detection (Amersham Biosciences).
Assay of PLC activity
Phosphatidylinositol 4,5-bisphosphate (PIP 2 ) hydrolytic activity of recombinant PLC proteins was assayed as described previously. The final concentration of PIP 2 in the reaction mixture was 220 mM, containing 0. admixture, as described previously (Nomikos et al., 2005; 2011a, b) .
cRNA synthesis
Following linearization of wild-type and chimeric PLCz plasmids, cRNA was synthesized using the mMessage Machine T7 kit (Ambion) and then was polyadenylated using the poly(A) tailing kit (Ambion), as per the manufacturer's instructions.
Preparation and handling of gametes
Female mice were superovulated and mature MII oocytes were collected 13.5-14.5 h after injection of human chorionic gonadotrophin and maintained in droplets of M2 media (Sigma) or H-KSOM under mineral oil at 378C. Microinjection and experimental recordings of Ca 2+ release or luciferase expression were carried out with mouse oocytes in Hepes-buffered media (H-KSOM) as described previously (Swann, 2013) . All compounds were from Sigma unless stated otherwise. All procedures using animals were performed in accordance with the UK Home Office Animals Procedures Act and were approved by the Cardiff University Animals Ethics Committee.
Microinjection and measurement of intracellular Ca 21 and luciferase expression
Mouse oocytes were washed in M2 and microinjected with cRNA diluted in injection buffer (120 mM KCl, 20 mM Hepes, pH 7.4). The volume injected was estimated from the diameter of cytoplasmic displacement caused by the bolus injection. All injections were 3 -5% of the oocyte volume. Oocytes were microinjected with the appropriate cRNA, mixed with an equal volume of 1 mM Oregon Green BAPTA dextran, OGBD (Molecular Probes) or 1 mM Rhod Dextran (Molecular Probes) in the injection buffer. For simple fluorescence recordings, oocytes were maintained in H-KSOM following microinjection and imaged on a Nikon Eclipse Ti-U microscope equipped with a cooled CCD camera (Coolsnap HQ?, Photometrics, USA) . When both luminescence and fluorescence were to be recorded, oocytes were maintained in H-KSOM containing 100 mM luciferin, and imaged on a Nikon TE2000 or a Zeiss Axiovert 100 microscope equipped with a cooled intensified CCD cameras (Photek Ltd, UK). The luminescence (for luciferase expression) and fluorescence (for Ca 2+ measurements) from oocytes were collected by switching back and forth between the two modes on a 10 s cycle (Campbell and Swann, 2006; Swann et al., 2009 ). These two signals are then displayed as two separate signals over the same time-period. The fluorescent light emitted by the Ca 2+ indicator is shown in relative units. The amount of luciferase was estimated from the luminescence from oocytes that were lysed in a luminometer, and this was compared with luminescence from recombinant luciferase protein used to generate a standard curve (Nomikos et al., 2005; Swann et al., 2009) . A conversion factor between the luminescence from the luminometer and the luminescence from the recording system was then calculated. All live imaging experiments on oocytes were made during a 3-month period.
Results
Expression and enzymatic characterization of recombinant PAWP protein
Initial attempts to express and purify PAWP either as an untagged or as a 6xHis-tag protein using prokaryotic expression proved unsuccessful as the protein appeared to be completely insoluble, accumulating into inclusion bodies. We have recently demonstrated that NusA is an extremely effective fusion protein partner for PLCz, significantly increasing the bacterial expression and yield of soluble PLCz protein, as well as enhancing the stability of the purified fusion protein over time (Nomikos et al., 2013b; Theodoridou et al., 2013) . Thus, mouse PAWP was cloned into the pETMM60 vector and purified as NusA-tagged fusion protein (Fig. 1) . In addition to PAWP, both the NusA-tagged mouse PLCz and rat PLCd1 that we have previously characterized (Theodoridou et al., 2013; Nomikos et al., 2014) were expressed and purified using the same bacterial expression system, and served as comparative standards for our studies. As described in 'Materials and Methods', optimal protein production for all NusA fusion constructs required induction of protein expression with 0.1 mM IPTG for 18 h at 168C. Following induced expression in E. coli and isolation by affinity chromatography, the purified protein samples were characterized. Figure 2 shows NusA-tagged PAWP, PLCz and PLCd1 recombinant proteins analysed by SDS -PAGE and immunoblot detection using an anti-His (penta-His) mouse monoclonal antibody. The dominant protein band with mobility corresponding to the predicted molecular mass for each construct was observed for all recombinant proteins (PAWP 98 kDa, PLCz 134 kDa and PLCd1 146 kDa). These major bands were also confirmed by the penta-His antibody after immunoblot analysis ( Fig. 2 ; right panels). For PLCz and PLCd1, additional low molecular weight bands could be observed, which were also detected by the penta-His antibody, and are probably the result of protease degradation occurring during the stages of protein isolation.
The specific PIP 2 hydrolytic enzyme activity for each recombinant protein was determined by the standard [ 3 H]PIP 2 hydrolysis assay.
The histogram in Fig. 3 (Fig. 3) .
To investigate whether PAWP has any modulatory effect on the PIP 2 hydrolytic enzyme activity of PLCz or PLCd1, we pre-incubated PLCz and PLCd1 proteins with equal (0.25 mM) or 4× fold excess (1 mM) of PAWP recombinant protein and then we tested their specific PIP 2 hydrolytic activities at 1 mM and 1 mM Ca 2+ . As shown in Fig. 4A 
Comparison of Ca 21 oscillation-inducing activities of PAWP and PLCz in unfertilized mouse oocytes
We then directly compared the Ca 2+ oscillation-inducing activities of recombinant NusA-tagged PLCz and PAWP proteins in unfertilized mouse Figure 1 Schematic representations of the various PAWP expression plasmid constructs generated for cRNA and recombinant protein production, together with the respective amino acid sequence lengths of NusA, YFP, firefly luciferase and mouse PAWP.
Figure 2 Expression and purification of recombinant NusA-6xHis-tagged PAWP (A), PLCz (B) and PLCd1(C) recombinant proteins. Affinity-purified, fusion proteins (1 mg) were analysed by 7.5% SDS -PAGE followed by either Coomassie Brilliant Blue staining (left panels) or immunoblot analysis (right panels) using the Penta-His monoclonal antibody (1 : 5000 dilution).
oocytes. As we have previously reported, NusA protein microinjection alone does not cause any Ca 2+ changes (Nomikos et al., 2013b) . Microinjection of recombinant mouse PAWP protein (with a pipette concentration of 0.5 mg/ml) failed to trigger Ca 2+ oscillations in any of the unfertilized mouse oocytes (Fig. 5A ). In contrast, microinjection of recombinant mouse PLCz protein into mouse oocytes caused a distinctive series of cytosolic Ca 2+ oscillations (Fig. 5B ) similar to those previously reported . To investigate whether the lack of Ca 2+ -oscillation-inducing activity of recombinant NusA-tagged PAWP protein was due to the NusA moiety, we next microinjected cRNA encoding an untagged mouse PAWP into unfertilized mouse oocytes. Oocytes were microinjected with a pipette cRNA concentration of 1.25 mg/ml. As shown in Fig. 6A (left panel), untagged PAWP was unable to induce any Ca 2+ release in mouse oocytes, in contrast with untagged PLCz where microinjection of 0.04 mg/ml cRNA triggered high frequency Ca 2+ oscillations similar to those observed upon microinjection of concentrated sperm extracts into mouse oocytes (Fig. 6A, right panel) . To confirm that PAWP cRNA was faithfully expressed in mouse oocytes, we microinjected mouse oocytes with cRNA encoding a YFP-PAWP fusion construct. As shown in Fig. 6B , microinjection of 1.5 mg/ml cRNA corresponding to YFP-PAWP showed high levels of expression YFP-PAWP protein in mouse oocytes (right panel), but this fusion protein was completely lacking in Ca 2+ -oscillation-inducing activity (left panel). The YFP-PAWP protein did not show any obvious subcellular localization pattern but appeared to remain evenly dispersed throughout the oocyte cytoplasm (Fig. 6B, right panel) . Whilst none of the YFP-PAWP cRNA-injected oocytes formed pronuclei, we noticed that 5/23 oocytes did form second polar bodies after 5 h. This was similar to the untagged PAWP cRNA injections, where 4/28 oocytes formed second polar bodies. Finally, using another approach to directly compare the Ca 2+ oscillation-inducing abilities of PAWP and PLCz in relation to their relative expression levels in mouse oocytes (as we have demonstrated previously with PLCz), we generated a PAWP fusion construct in which PAWP was C-terminally tagged with firefly luciferase. This strategy to measure PAWP-luciferase luminescence in living cells enables real-time monitoring of relative protein expression, while concurrently measuring Ca 2+ levels (Swann et al., 2009) . Prominent Ca 2+ oscillations were observed in PLCz cRNA-injected mouse oocytes at a luminescence reading of 3.9 counts per second, corresponding to protein expression of 59 fg PLCz/oocyte (Fig. 7, bottom trace) . Recombinant PLCz-luc triggered somewhat higher frequency Ca 2+ oscillations when expressed at 360 fg/oocyte (Fig. 8, bottom trace) . However, microinjection of PAWP-luc completely failed to cause a detectable Ca 2+ increase in any injected oocytes, either when the recombinant protein was expressed at 89 fg/oocyte (Fig. 7, top trace) , or at 1.6 pg/oocyte (Fig. 8, top  trace) . These data suggest that recombinant mouse PAWP protein is unable to initiate any Ca 2+ increase in mouse oocytes. We also observed that none of the PAWP-luc injected oocytes formed pronuclei. However, we found that 6/45 PAWP-luc injected oocytes formed a second polar body. This effect was unrelated to the amount of PAWP-luc protein expressed, but the rate was marginally higher than the rate of second polar body formation with control luciferase-expressing oocytes (1/19). These data suggest there may be a minor effect of PAWP in promoting second polar body formation. However, since none of the PAWP-injected oocytes showed any sign of a Ca 2+ increase, this minor effect is unrelated to changes in intracellular Ca 2+ signalling.
Discussion
In all animal species studied to date, oocyte activation involves increases in the concentration of oocyte cytosolic Ca 2+ , which are both necessary and sufficient for stimulating embryo development (Stricker, 1999) . In mammals, such increases consist of a series of Ca 2+ oscillations that last several hours (Miyazaki et al., 1993; Nomikos et al., 2013a) . To date, only one sperm-derived molecule, PLCz, has been shown to cause Ca 2+ oscillations similar to those seen at fertilization Lee et al., 2006) . Nevertheless, it has been suggested by one laboratory group that the sperm protein PAWP is the agent used by the sperm to activate development in mammals (Wu et al., 2007; Aarabi et al., 2010) . This suggestion is partly based on the finding that PAWP can cause pronuclear formation when injected into bovine, monkey, pig and Xenopus oocytes (Wu et al., 2007) , and that its injection into Xenopus oocytes can cause an increase in intracellular Ca 2+ concentrations (Aarabi et al., 2010) . These data specifically beg the obvious question as to whether PAWP can trigger the appropriate pattern of Ca 2+ oscillations in a mammalian oocyte, which has yet to be clearly resolved. Therefore, in this study, we have utilized mouse oocytes to address this question regarding PAWP's efficacy, as such cells are the most studied model system for signal transduction at fertilization in mammals, and there is extensive knowledge of the mechanism of Ca 2+ oscillations and the downstream effectors (Miyazaki et al., 1993; Lee et al., 2006; Ducibella and Fissore, 2007) . In an extensive series of experiments, we have found that mouse recombinant PAWP protein was unable to cause Ca 2+ oscillations in mouse oocytes. Furthermore, expressing PAWP in mouse oocytes by injecting the corresponding cRNA did not lead to any form of Ca 2+ increase. This was the case regardless of whether we expressed a C-or N-terminal tagged construct of PAWP, or whether we injected untagged PAWP. All of these methods have been successfully used to express PLCz in mouse oocytes in a way that allows it to trigger sustained cytoplasmic Ca 2+ oscillations. The amount of PAWP we introduced into mouse oocytes was at least as much, and sometimes considerably more than that used in previous studies. PAWP was previously reported to be effective in activating pig, bovine and monkey oocytes at final concentration ranges of 100 fg to 2.5 pg/oocyte (Wu et al., 2007) . The expression range calculated for our PAWP-luc experiments was also from 100 fg to 2 pg/oocyte. For the YFP-PAWP experiments, we do not have an absolute calibration. However, since fluorescent proteins need to be expressed at 1 mM to be detectable (Niswender et al., 1995) the final expression levels of YFP-PAWP in our experiments would likely be 10 pg/oocyte. Mouse oocytes are several times smaller than pig or cow oocytes so the effective concentrations that we have used would likely be several times higher than those used in pig, bovine and monkey oocytes. We monitored expression from just after the injection of cRNA, when expression was undetectable, all the way up to maximal values (0.1 -10 pg). However, we were unable to observe any Ca 2+ oscillations throughout the entire period of expression, effectively monitoring the effects of PAWP over a wide range of concentrations from zero to many times higher than that reported in previous studies. Consequently, the current data suggest that PAWP is ineffective at causing Ca 2+ release in mammalian oocytes over a wide range of concentrations. The only PAWP effect we noticed in some of our experiments was a slight increase in the number of oocytes that formed second polar bodies after PAWP injection. This was a small and inconsistent effect, and not associated with Ca 2+ increases, and so was difficult to investigate any further.
PAWP is an alkaline protein that shares sequence homology to the N-terminal half of WW domain-binding protein 2, while the C-terminal half is rich in proline residues. PAWP does not have any predicted enzymatic activity, and our data suggest that it does not possess any PLC hydrolytic activity, nor the ability to act as a generic activator of PLC activity. So, it may be reasonable to assume that PAWP mediates its effects in oocytes via interaction with other proteins. It has been suggested that PAWP effects are via an interaction with Yes associated proteins that ultimately work through a Src-like kinase, and hence PLCg (Wu et al., 2007) . Previous studies have shown that artificial stimulation of the PLCg pathway, via exogenous expression of growth factor receptors, causes Ca 2+ oscillations in mouse oocytes (Mehlmann et al., 1998) .
Hence, for PAWP to mediate its effects via this pathway, it would be expected to generate IP 3 and Ca 2+ oscillations. However, since we found no evidence for any PAWP-induced Ca 2+ oscillations in mouse oocytes under the same conditions where PLCz was fully effective, and using the same methods and set of tagged constructs that are fully functional with PLCz, it seems unlikely that PAWP mediates any of its proposed oocyte-activating ability via this pathway. It should also be noted that injecting excess SH2 domains to block PLCg-mediated signalling in mouse oocytes, does not block Ca 2+ oscillations in fertilizing mouse oocytes (Mehlmann et al., 1998 (Aarabi et al., 2010) . However, in the study by Aarabi et al., it was not clear whether PAWP triggered the same type of Ca 2+ increase that has previously been reported for fertilization in this species. In Xenopus oocytes, the sperm stimulates a distinctive and regenerative Ca 2+ wave that crosses the oocyte in 5 min (Fontanilla and Nuccitelli, 1998) . Such a distinctive Ca 2+ wave is also stimulated by injection of IP 3 (Busa et al., 1985) , or by mammalian cytosolic sperm extracts (Wu et al., 2001) . However, the PAWP-induced Ca 2+ increase did not show wave-like characteristics. Nevertheless, it was claimed that PAWP in Xenopus and mammalian oocytes is relevant to fertilization, because the ability of PAWP, or sperm, to activate oocytes is blocked by prior injection of PPXY motif-containing peptides (Aarabi et al., 2010) . However, the specificity of these peptides is unclear since there were no controls used to investigate whether these peptides exert an inhibitory action upon pronuclear formation itself. It remains possible that the inhibitory effects of these peptides, in mammalian oocytes at least, are mediated downstream of Ca 2+ signalling events which involve a range of protein kinases (Ducibella and Fissore, 2007) . Since there appears to be a negligible effect of PAWP on mouse oocytes, it is difficult to test any other role for this protein in this species. Regardless of how PAWP may mediate the previously reported effects in oocytes, our present data clearly suggest that PAWP does not initiate the Ca 2+ oscillations required to activate the mouse oocyte at fertilization. Furthermore, unlike PLCz, our current data suggests that PAWP cannot be used as an agent to induce artificial oocyte activation in mammals.
